PSME2 promotes malignant progression through autophagy modulation via IL-6/STAT3 signaling pathway in esophageal squamous cell carcinoma
Life Sciences · 2025
DOI: 10.1016/j.lfs.2025.123749 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2025. Verfasst von Kui Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Esophageal Cancer Prevention & Treatment, Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, …. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Autophagy, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
AIMS: This study aims to investigate the expression, clinical relevance, and functional roles of PSME2 in esophageal squamous cell carcinoma (ESCC). MATERIALS AND METHODS: The biomarkers for ESCC were identified through comprehensive analysis of publicly available mRNA transcriptome data obtained from TCGA and GEO databases. The mRNA and protein expression levels of PSME2 in ESCC were validated using two independent cohorts of ESCC samples. The proliferation, migration, invasion, and autophagy activity of ESCC cells were evaluated in vitro through the knockdown of PSME2 or PR171. The effects of the knockdown of PSME2, STAT3 inhibitor WP1066, and autophagy inhibitor chloroquine on the tumorigenic potential of ESCC cells were also assessed through an in vivo subcutaneous tumor model established in nude mice. KEY FINDINGS: The result obtained indicates the upregulation of PSME2 in ESCC, suggesting poor prognosis. The result also shows that the knockdown of PSME2 and PR171 triggers the reduction in ESCC cell proliferation, migration, and invasion. Thus, it buttresses the fact that PSME2 knockdown induced autophagy through the IL6/STAT3 pathway, leading to cell death resistance. The result also linked the suppression of tumor growth to the knockdown of PSME2 and WP1066 or chloroquine, suggesting that targeting these proteins may be a potential therapeutic strategy for inhibiting tumor progression. SIGNIFICANCE: The study shows the promising role of PSME2 as a therapeutic target in ESCC management. The combined inhibition of PSME2 and activated pathways ensures effective suppression of tumor growth and proliferation, thus offering a novel strategy for better treatment outcomes in ESCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Esophageal Cancer Prevention & Treatment, Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First…
- Department of Mathematics and Physics, Luoyang Institute of Science and Technology, Luoyang 471023, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Sun, K., Liu, Y. X., Li, M. X., Qi, C. H., Wu, X. S., Kang, Y. A., Zhao, D., Zhang, Z. C., Du, Y. B., Gao, S. G., & Qi, Y. J. (2025). PSME2 promotes malignant progression through autophagy modulation via IL-6/STAT3 signaling pathway in esophageal squamous cell carcinoma. Life Sciences. https://doi.org/10.1016/j.lfs.2025.123749
Vancouver
Sun K, Liu YX, Li MX, Qi CH, Wu XS, Kang YA, et al. PSME2 promotes malignant progression through autophagy modulation via IL-6/STAT3 signaling pathway in esophageal squamous cell carcinoma. Life Sciences. 2025. doi:10.1016/j.lfs.2025.123749
BibTeX
@article{Sun2025,
author = {Sun, Kui and Liu, Yong-Xuan and Li, Meng-Xiang and Qi, Chun-Hui and Wu, Xiao-Shuang and Kang, Yong-An and Zhao, Di and Zhang, Zi-Chao and Du, Yu-Bo and Gao, She-Gan and Qi, Yi-Jun},
title = {PSME2 promotes malignant progression through autophagy modulation via IL-6/STAT3 signaling pathway in esophageal squamous cell carcinoma},
journal = {Life Sciences},
year = {2025},
doi = {10.1016/j.lfs.2025.123749}
}
EUVIMED